Project Number AARF-22-928286 Agency/Funding Organization Alzheimer's Association Funding Year 2022 View Full Project Details for Role of CLDN5 and blood brain barrier damage in Tauopathies Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau c. Tau-Mediated Pathogenesis (AD and ADRD) Researcher and Organization Principal Investigator Orsini, Franca Principal Investigator Orsini, Franca Awardee Organization Mario Negri Institute for Pharmacological Research (Instituto di Ricerche Farmacologiche Mario Negri) Contact PI Country Italy Project Detail Funding Opportunity Announcement AARF FY Overall Cost $174,990 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Alzheimer's Association
